ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccine for Influenza Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-3B8011
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Vaccine for Influenza Market Insights Forecast to 2028
BUY CHAPTERS

Global Vaccine for Influenza Market Research Report 2025

Code: QYRE-Auto-3B8011
Report
March 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
CSL Limited
GSK
Astrazeneca plc
Viatris
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics

Vaccine for Influenza Market Size

The global market for Vaccine for Influenza was valued at US$ 8955 million in the year 2024 and is projected to reach a revised size of US$ 12990 million by 2031, growing at a CAGR of 5.5% during the forecast period.

Vaccine for Influenza Market

Vaccine for Influenza Market

Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vaccine for Influenza, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine for Influenza.
The Vaccine for Influenza market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccine for Influenza market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine for Influenza manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Vaccine for Influenza Market Report

Report Metric Details
Report Name Vaccine for Influenza Market
Accounted market size in year US$ 8955 million
Forecasted market size in 2031 US$ 12990 million
CAGR 5.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • 6 Months to 3 Years
  • > 3 Years
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vaccine for Influenza manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Vaccine for Influenza in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Vaccine for Influenza Market growing?

Ans: The Vaccine for Influenza Market witnessing a CAGR of 5.5% during the forecast period 2025-2031.

What is the Vaccine for Influenza Market size in 2031?

Ans: The Vaccine for Influenza Market size in 2031 will be US$ 12990 million.

What is the market share of major companies in Vaccine for Influenza Market?

Ans: The top five players hold a share about 75%.

What is the Vaccine for Influenza Market share by region?

Ans: North America is the largest market, has a share about 50%.

Who are the main players in the Vaccine for Influenza Market report?

Ans: The main players in the Vaccine for Influenza Market are Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics

What are the Application segmentation covered in the Vaccine for Influenza Market report?

Ans: The Applications covered in the Vaccine for Influenza Market report are 6 Months to 3 Years, > 3 Years

What are the Type segmentation covered in the Vaccine for Influenza Market report?

Ans: The Types covered in the Vaccine for Influenza Market report are Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine

Recommended Reports

Influenza Vaccines

General Vaccine Markets

Vaccine Supply Chain

1 Vaccine for Influenza Market Overview
1.1 Product Definition
1.2 Vaccine for Influenza by Type
1.2.1 Global Vaccine for Influenza Market Value Comparison by Type (2024 VS 2031)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Vaccine for Influenza by Application
1.3.1 Global Vaccine for Influenza Market Value by Application (2024 VS 2031)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Vaccine for Influenza Market Size Estimates and Forecasts
1.4.1 Global Vaccine for Influenza Revenue 2020-2031
1.4.2 Global Vaccine for Influenza Sales 2020-2031
1.4.3 Global Vaccine for Influenza Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vaccine for Influenza Market Competition by Manufacturers
2.1 Global Vaccine for Influenza Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vaccine for Influenza Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vaccine for Influenza Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vaccine for Influenza, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccine for Influenza, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccine for Influenza, Product Type & Application
2.7 Global Key Manufacturers of Vaccine for Influenza, Date of Enter into This Industry
2.8 Global Vaccine for Influenza Market Competitive Situation and Trends
2.8.1 Global Vaccine for Influenza Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Vaccine for Influenza Players Market Share by Revenue
2.8.3 Global Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaccine for Influenza Market Scenario by Region
3.1 Global Vaccine for Influenza Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vaccine for Influenza Sales by Region: 2020-2031
3.2.1 Global Vaccine for Influenza Sales by Region: 2020-2025
3.2.2 Global Vaccine for Influenza Sales by Region: 2026-2031
3.3 Global Vaccine for Influenza Revenue by Region: 2020-2031
3.3.1 Global Vaccine for Influenza Revenue by Region: 2020-2025
3.3.2 Global Vaccine for Influenza Revenue by Region: 2026-2031
3.4 North America Vaccine for Influenza Market Facts & Figures by Country
3.4.1 North America Vaccine for Influenza Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vaccine for Influenza Sales by Country (2020-2031)
3.4.3 North America Vaccine for Influenza Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaccine for Influenza Market Facts & Figures by Country
3.5.1 Europe Vaccine for Influenza Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vaccine for Influenza Sales by Country (2020-2031)
3.5.3 Europe Vaccine for Influenza Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine for Influenza Market Facts & Figures by Region
3.6.1 Asia Pacific Vaccine for Influenza Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vaccine for Influenza Sales by Region (2020-2031)
3.6.3 Asia Pacific Vaccine for Influenza Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vaccine for Influenza Market Facts & Figures by Country
3.7.1 Latin America Vaccine for Influenza Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vaccine for Influenza Sales by Country (2020-2031)
3.7.3 Latin America Vaccine for Influenza Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccine for Influenza Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine for Influenza Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vaccine for Influenza Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vaccine for Influenza Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccine for Influenza Sales by Type (2020-2031)
4.1.1 Global Vaccine for Influenza Sales by Type (2020-2025)
4.1.2 Global Vaccine for Influenza Sales by Type (2026-2031)
4.1.3 Global Vaccine for Influenza Sales Market Share by Type (2020-2031)
4.2 Global Vaccine for Influenza Revenue by Type (2020-2031)
4.2.1 Global Vaccine for Influenza Revenue by Type (2020-2025)
4.2.2 Global Vaccine for Influenza Revenue by Type (2026-2031)
4.2.3 Global Vaccine for Influenza Revenue Market Share by Type (2020-2031)
4.3 Global Vaccine for Influenza Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vaccine for Influenza Sales by Application (2020-2031)
5.1.1 Global Vaccine for Influenza Sales by Application (2020-2025)
5.1.2 Global Vaccine for Influenza Sales by Application (2026-2031)
5.1.3 Global Vaccine for Influenza Sales Market Share by Application (2020-2031)
5.2 Global Vaccine for Influenza Revenue by Application (2020-2031)
5.2.1 Global Vaccine for Influenza Revenue by Application (2020-2025)
5.2.2 Global Vaccine for Influenza Revenue by Application (2026-2031)
5.2.3 Global Vaccine for Influenza Revenue Market Share by Application (2020-2031)
5.3 Global Vaccine for Influenza Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Vaccine for Influenza Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Vaccine for Influenza Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Vaccine for Influenza Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Vaccine for Influenza Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Vaccine for Influenza Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Vaccine for Influenza Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Vaccine for Influenza Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Viatris Vaccine for Influenza Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Company Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Vaccine for Influenza Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AstraZeneca Vaccine for Influenza Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Company Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Vaccine for Influenza Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hualan Bio Vaccine for Influenza Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.7.1 Changchun Institute of Biological Company Information
6.7.2 Changchun Institute of Biological Description and Business Overview
6.7.3 Changchun Institute of Biological Vaccine for Influenza Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Changchun Institute of Biological Vaccine for Influenza Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Company Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Vaccine for Influenza Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sinovac Vaccine for Influenza Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Company Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Vaccine for Influenza Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BCHT Vaccine for Influenza Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Company Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Vaccine for Influenza Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jiangsu GDK Vaccine for Influenza Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Company Information
6.11.2 KM Biologics Description and Business Overview
6.11.3 KM Biologics Vaccine for Influenza Sales, Revenue and Gross Margin (2020-2025)
6.11.4 KM Biologics Vaccine for Influenza Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine for Influenza Industry Chain Analysis
7.2 Vaccine for Influenza Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine for Influenza Production Mode & Process Analysis
7.4 Vaccine for Influenza Sales and Marketing
7.4.1 Vaccine for Influenza Sales Channels
7.4.2 Vaccine for Influenza Distributors
7.5 Vaccine for Influenza Customer Analysis
8 Vaccine for Influenza Market Dynamics
8.1 Vaccine for Influenza Industry Trends
8.2 Vaccine for Influenza Market Drivers
8.3 Vaccine for Influenza Market Challenges
8.4 Vaccine for Influenza Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
CSL Limited
GSK
Astrazeneca plc
Viatris
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
List of Tables
 Table 1. Global Vaccine for Influenza Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Vaccine for Influenza Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Vaccine for Influenza Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Vaccine for Influenza Sales (M Units) of Key Manufacturers (2020-2025)
 Table 5. Global Vaccine for Influenza Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Vaccine for Influenza Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Vaccine for Influenza Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Vaccine for Influenza Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Vaccine for Influenza, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Vaccine for Influenza, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Vaccine for Influenza, Product Type & Application
 Table 12. Global Key Manufacturers of Vaccine for Influenza, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Vaccine for Influenza by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine for Influenza as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Vaccine for Influenza Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Vaccine for Influenza Sales by Region (2020-2025) & (M Units)
 Table 18. Global Vaccine for Influenza Sales Market Share by Region (2020-2025)
 Table 19. Global Vaccine for Influenza Sales by Region (2026-2031) & (M Units)
 Table 20. Global Vaccine for Influenza Sales Market Share by Region (2026-2031)
 Table 21. Global Vaccine for Influenza Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Vaccine for Influenza Revenue Market Share by Region (2020-2025)
 Table 23. Global Vaccine for Influenza Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Vaccine for Influenza Revenue Market Share by Region (2026-2031)
 Table 25. North America Vaccine for Influenza Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Vaccine for Influenza Sales by Country (2020-2025) & (M Units)
 Table 27. North America Vaccine for Influenza Sales by Country (2026-2031) & (M Units)
 Table 28. North America Vaccine for Influenza Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Vaccine for Influenza Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Vaccine for Influenza Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Vaccine for Influenza Sales by Country (2020-2025) & (M Units)
 Table 32. Europe Vaccine for Influenza Sales by Country (2026-2031) & (M Units)
 Table 33. Europe Vaccine for Influenza Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Vaccine for Influenza Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Vaccine for Influenza Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Vaccine for Influenza Sales by Region (2020-2025) & (M Units)
 Table 37. Asia Pacific Vaccine for Influenza Sales by Region (2026-2031) & (M Units)
 Table 38. Asia Pacific Vaccine for Influenza Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Vaccine for Influenza Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Vaccine for Influenza Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Vaccine for Influenza Sales by Country (2020-2025) & (M Units)
 Table 42. Latin America Vaccine for Influenza Sales by Country (2026-2031) & (M Units)
 Table 43. Latin America Vaccine for Influenza Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Vaccine for Influenza Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Vaccine for Influenza Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Vaccine for Influenza Sales by Country (2020-2025) & (M Units)
 Table 47. Middle East and Africa Vaccine for Influenza Sales by Country (2026-2031) & (M Units)
 Table 48. Middle East and Africa Vaccine for Influenza Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Vaccine for Influenza Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Vaccine for Influenza Sales (M Units) by Type (2020-2025)
 Table 51. Global Vaccine for Influenza Sales (M Units) by Type (2026-2031)
 Table 52. Global Vaccine for Influenza Sales Market Share by Type (2020-2025)
 Table 53. Global Vaccine for Influenza Sales Market Share by Type (2026-2031)
 Table 54. Global Vaccine for Influenza Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Vaccine for Influenza Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Vaccine for Influenza Revenue Market Share by Type (2020-2025)
 Table 57. Global Vaccine for Influenza Revenue Market Share by Type (2026-2031)
 Table 58. Global Vaccine for Influenza Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Vaccine for Influenza Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Vaccine for Influenza Sales (M Units) by Application (2020-2025)
 Table 61. Global Vaccine for Influenza Sales (M Units) by Application (2026-2031)
 Table 62. Global Vaccine for Influenza Sales Market Share by Application (2020-2025)
 Table 63. Global Vaccine for Influenza Sales Market Share by Application (2026-2031)
 Table 64. Global Vaccine for Influenza Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Vaccine for Influenza Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Vaccine for Influenza Revenue Market Share by Application (2020-2025)
 Table 67. Global Vaccine for Influenza Revenue Market Share by Application (2026-2031)
 Table 68. Global Vaccine for Influenza Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Vaccine for Influenza Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Vaccine for Influenza Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. CSL Company Information
 Table 76. CSL Description and Business Overview
 Table 77. CSL Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. CSL Vaccine for Influenza Product
 Table 79. CSL Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GSK Vaccine for Influenza Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Viatris Company Information
 Table 86. Viatris Description and Business Overview
 Table 87. Viatris Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Viatris Vaccine for Influenza Product
 Table 89. Viatris Recent Developments/Updates
 Table 90. AstraZeneca Company Information
 Table 91. AstraZeneca Description and Business Overview
 Table 92. AstraZeneca Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. AstraZeneca Vaccine for Influenza Product
 Table 94. AstraZeneca Recent Developments/Updates
 Table 95. Hualan Bio Company Information
 Table 96. Hualan Bio Description and Business Overview
 Table 97. Hualan Bio Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Hualan Bio Vaccine for Influenza Product
 Table 99. Hualan Bio Recent Developments/Updates
 Table 100. Changchun Institute of Biological Company Information
 Table 101. Changchun Institute of Biological Description and Business Overview
 Table 102. Changchun Institute of Biological Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Changchun Institute of Biological Vaccine for Influenza Product
 Table 104. Changchun Institute of Biological Recent Developments/Updates
 Table 105. Sinovac Company Information
 Table 106. Sinovac Description and Business Overview
 Table 107. Sinovac Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sinovac Vaccine for Influenza Product
 Table 109. Sinovac Recent Developments/Updates
 Table 110. BCHT Company Information
 Table 111. BCHT Description and Business Overview
 Table 112. BCHT Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. BCHT Vaccine for Influenza Product
 Table 114. BCHT Recent Developments/Updates
 Table 115. Jiangsu GDK Company Information
 Table 116. Jiangsu GDK Description and Business Overview
 Table 117. Jiangsu GDK Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Jiangsu GDK Vaccine for Influenza Product
 Table 119. Jiangsu GDK Recent Developments/Updates
 Table 120. KM Biologics Company Information
 Table 121. KM Biologics Description and Business Overview
 Table 122. KM Biologics Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. KM Biologics Vaccine for Influenza Product
 Table 124. KM Biologics Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Vaccine for Influenza Distributors List
 Table 128. Vaccine for Influenza Customers List
 Table 129. Vaccine for Influenza Market Trends
 Table 130. Vaccine for Influenza Market Drivers
 Table 131. Vaccine for Influenza Market Challenges
 Table 132. Vaccine for Influenza Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Vaccine for Influenza
 Figure 2. Global Vaccine for Influenza Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Vaccine for Influenza Market Share by Type: 2024 & 2031
 Figure 4. Trivalent Influenza Vaccine Product Picture
 Figure 5. Quadrivalent Influenza Vaccine Product Picture
 Figure 6. Global Vaccine for Influenza Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Vaccine for Influenza Market Share by Application: 2024 & 2031
 Figure 8. 6 Months to 3 Years
 Figure 9. > 3 Years
 Figure 10. Global Vaccine for Influenza Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Vaccine for Influenza Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Vaccine for Influenza Sales (2020-2031) & (M Units)
 Figure 13. Global Vaccine for Influenza Average Price (US$/Unit) & (2020-2031)
 Figure 14. Vaccine for Influenza Report Years Considered
 Figure 15. Vaccine for Influenza Sales Share by Manufacturers in 2024
 Figure 16. Global Vaccine for Influenza Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Vaccine for Influenza Players: Market Share by Revenue in Vaccine for Influenza in 2024
 Figure 18. Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Vaccine for Influenza Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Vaccine for Influenza Sales Market Share by Country (2020-2031)
 Figure 21. North America Vaccine for Influenza Revenue Market Share by Country (2020-2031)
 Figure 22. United States Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Vaccine for Influenza Sales Market Share by Country (2020-2031)
 Figure 25. Europe Vaccine for Influenza Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Vaccine for Influenza Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Vaccine for Influenza Revenue Market Share by Region (2020-2031)
 Figure 33. China Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Vaccine for Influenza Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Vaccine for Influenza Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Vaccine for Influenza Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Vaccine for Influenza Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Vaccine for Influenza Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Vaccine for Influenza by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Vaccine for Influenza by Type (2020-2031)
 Figure 52. Global Vaccine for Influenza Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Vaccine for Influenza by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Vaccine for Influenza by Application (2020-2031)
 Figure 55. Global Vaccine for Influenza Price (US$/Unit) by Application (2020-2031)
 Figure 56. Vaccine for Influenza Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Pandemic Influenza Vaccine Market Research Report 2025
Global Influenza Drugs and Vaccines Market Research Report 2025
Inactivated Influenza Vaccine Market
Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Trivalent Inactivated Influenza Vaccine Market Research Report 2025
Global Inactivated Influenza Virus Vaccine Market Research Report 2025
Cell based Flu Vaccine Market
Needle Free Influenza Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Trivalent Flu Vaccine Market Insights Forecast to 2030
Global Quadrivalent Flu Vaccine Market Insights Forecast to 2030
Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Multivalent Influenza Vaccines Market Research Report 2025
Global Viral Vaccines Market Research Report 2025
Influenza Virus Vaccine H1N1 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Injection Influenza Vaccine Market Research Report 2025
Swine Influenza Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza Antiviral Drugs Market
Anti influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cattle Vaccine Market Research Report 2025
Global Influenza Therapeutics Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions